JPMorgan upgrades Illumina to Overweight from Neutral and raises its price target to $185 from $125
JPMorgan upgrades Illumina to Overweight from Neutral and raises its price target to $185 from $125, citing customer stickiness and favorable recent survey results.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.